CGTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.75%

Insider Buying (Last 12 Months): $9,975.00

Insider Selling (Last 12 Months): $0.00

Cognition Therapeutics Insider Trading History Chart

Cognition Therapeutics Share Price & Price History

^$0.42

▼ -0.0093 (-2.19%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Cognition Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/14/2024	Lisa Ricciardi	CEO	Buy	5,700	$1.75	$9,975.00	291,345
11/29/2022	Ellen B Richstone	Director	Buy	10,000	$2.65	$26,500.00	10,000
11/15/2022	Lisa Ricciardi	CEO	Buy	12,000	$1.30	$15,600.00	24,500
11/15/2022	Peggy Wallace	Director	Buy	12,500	$1.20	$15,000.00	37,961

SEC Filings (Institutional Ownership Changes) for Cognition Therapeutics (NASDAQ:CGTX)

43.35% of Cognition Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cognition Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Two Sigma Investments LP	53,691	$38K	0.0%	+372.2%	0.129%
2/14/2025	Voss Capital LP	500,000	$0.35M	0.0%	N/A	1.203%
2/12/2025	Geode Capital Management LLC	352,348	$0.25M	0.0%	+8.9%	0.848%
2/11/2025	Virtu Financial LLC	80,180	$56K	0.0%	+40.1%	0.193%
2/10/2025	BIOS Capital Management LP	6,000,000	$4.21M	4.5%	N/A	14.441%
2/7/2025	CM Management LLC	200,000	$0.14M	0.1%	-20.0%	0.481%
2/3/2025	Sigma Planning Corp	614,490	$0.43M	0.0%	+211.6%	1.479%
1/17/2025	SG Americas Securities LLC	37,108	$26K	0.0%	N/A	0.089%
11/20/2024	Virtu Financial LLC	57,231	$27K	0.0%	N/A	0.138%
11/4/2024	Sigma Planning Corp	197,190	$92K	0.0%	+14.6%	0.491%
8/12/2024	Mercer Global Advisors Inc. ADV	95,951	$0.16M	0.0%	+33.4%	0.240%
8/9/2024	Renaissance Technologies LLC	89,718	$0.15M	0.0%	-42.4%	0.224%
8/7/2024	AIGH Capital Management LLC	300,766	$0.50M	0.2%	-84.1%	0.751%
8/2/2024	CM Management LLC	200,000	$0.33M	0.3%	+14.3%	0.499%
7/16/2024	Bangor Savings Bank	34,019	$56K	0.0%	+41.6%	0.085%
5/16/2024	Levin Capital Strategies L.P.	30,000	$55K	0.0%	N/A	0.075%
5/16/2024	AWM Investment Company Inc.	650,000	$1.18M	0.2%	N/A	1.623%
5/14/2024	Carlson Capital L P	213,995	$0.39M	0.0%	-10.1%	0.534%
5/14/2024	CM Management LLC	175,000	$0.32M	0.3%	N/A	0.437%
5/10/2024	Tocqueville Asset Management L.P.	26,000	$47K	0.0%	N/A	0.065%
5/8/2024	Hohimer Wealth Management LLC	225,000	$0.41M	0.1%	N/A	0.562%
3/5/2024	Twin Focus Capital Partners LLC	93,372	$0.17M	0.0%	N/A	0.291%
2/8/2024	Texas Capital Bank Wealth Management Services Inc	55,395	$0.10M	0.0%	N/A	0.172%
2/1/2024	Sigma Planning Corp	28,550	$53K	0.0%	N/A	0.089%
10/23/2023	Steward Financial Group LLC	40,874	$58K	0.0%	N/A	0.135%
7/28/2023	Voss Capital LLC	60,222	$0.11M	0.0%	-62.4%	0.206%
5/12/2023	Voss Capital LLC	159,973	$0.32M	0.0%	-4.2%	0.546%
5/12/2023	FCA Corp TX	51,471	$0.10M	0.0%	N/A	0.176%
2/16/2023	AIGH Capital Management LLC	2,037,853	$4.28M	1.4%	+155.3%	7.030%
2/13/2023	Northeast Financial Consultants Inc	24,500	$51K	0.0%	N/A	0.085%
2/13/2023	Voss Capital LLC	166,903	$0.35M	0.1%	-23.8%	0.576%
2/13/2023	Financial Partners Capital Management LLC	14,228	$30K	0.0%	N/A	0.049%
2/7/2023	Commonwealth Equity Services LLC	189,307	$0.40M	0.0%	-13.6%	0.653%
2/6/2023	Neumann Capital Management LLC	33,382	$70K	0.0%	N/A	0.115%
1/31/2023	Kestra Advisory Services LLC	50,618	$0.11M	0.0%	+237.5%	0.175%
1/20/2023	Diligent Investors LLC	20,000	$42K	0.0%	-34.5%	0.069%
12/13/2022	Perigon Wealth Management LLC	36,900	$70K	0.0%	-70.0%	0.127%
11/15/2022	Carlson Capital L P	100,000	$0.19M	0.0%	N/A	0.440%
11/14/2022	Worth Venture Partners LLC	200,188	$0.38M	0.2%	-12.3%	0.881%
11/10/2022	Rock Creek Group LP	50,000	$95K	0.0%	-37.3%	0.220%
11/2/2022	Voss Capital LLC	219,100	$0.42M	0.1%	-29.2%	0.965%
11/1/2022	P.A.W. Capital Corp	100,000	$0.19M	0.3%	-25.9%	0.440%
10/12/2022	Wealth Alliance Advisory Group LLC	18,500	$35K	0.0%	N/A	0.081%
8/13/2022	Voss Capital LLC	309,472	$0.65M	0.2%	+1,070.5%	1.363%
8/13/2022	Prosight Management LP	120,198	$0.25M	0.2%	-49.9%	0.532%
8/11/2022	Perigon Wealth Management LLC	122,846	$0.26M	0.0%	N/A	0.544%
8/8/2022	Rock Creek Group LP	79,751	$0.17M	0.0%	+201.6%	0.353%
8/1/2022	Castle Wealth Management LLC	43,380	$92K	0.1%	N/A	0.192%
7/19/2022	Commonwealth Equity Services LLC	214,961	$0.45M	0.0%	+1,447.6%	0.951%
7/13/2022	P.A.W. Capital Corp	135,000	$0.29M	0.4%	+12.5%	0.597%
5/17/2022	Prosight Management LP	240,080	$0.66M	0.4%	-20.5%	1.062%
5/4/2022	Commonwealth Equity Services LLC	13,890	$38K	0.0%	N/A	0.061%
4/26/2022	Diligent Investors LLC	30,520	$84K	0.0%	N/A	0.135%
4/26/2022	Kestra Advisory Services LLC	238,666	$0.66M	0.0%	+150.9%	1.057%
4/21/2022	P.A.W. Capital Corp	120,000	$0.33M	0.3%	+20.0%	0.531%
4/14/2022	Bangor Savings Bank	18,496	$51K	0.0%	N/A	0.082%
2/10/2022	B. Riley Financial Inc.	30,904	$0.20M	0.0%	N/A	0.140%
2/10/2022	American Financial Group Inc.	205,000	$1.30M	0.4%	N/A	0.930%
2/10/2022	AIGH Capital Management LLC	25,496	$0.16M	0.0%	N/A	0.116%
2/10/2022	P.A.W. Capital Corp	100,000	$0.63M	0.6%	N/A	0.454%

Data available starting January 2016

See Full Table

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.

Today's Range

Now: $0.42

$0.41

$0.46

50 Day Range

MA: $0.62

$0.41

$0.85

52 Week Range

Now: $0.42

$0.34

$2.95

Volume

941,919 shs

Average Volume

1,874,921 shs

Market Capitalization

$17.24 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Cognition Therapeutics?: Cognition Therapeutics' top insider investors include:
Lisa Ricciardi (CEO)
Learn More about top insider investors at Cognition Therapeutics.
Who are the major institutional investors of Cognition Therapeutics?: Cognition Therapeutics' top institutional shareholders include:
BIOS Capital Management LP — 14.44%
Sigma Planning Corp — 1.48%
Voss Capital LP — 1.20%
Geode Capital Management LLC — 0.85%
CM Management LLC — 0.48%
Virtu Financial LLC — 0.19%
Learn More about top institutional investors of Cognition Therapeutics stock.
Which institutional investors are selling Cognition Therapeutics stock?: Within the last quarter, CGTX stock was sold by these institutional investors:
CM Management LLC
Which institutional investors are buying Cognition Therapeutics stock?: During the last quarter, CGTX stock was bought by institutional investors including:
BIOS Capital Management LP
Voss Capital LP
Sigma Planning Corp
Two Sigma Investments LP
SG Americas Securities LLC
Geode Capital Management LLC
Virtu Financial LLC